Rocket Lab Shares Tumble Following Resurfaced Short Seller Analysis

A single social media post triggered a significant selloff in one of the space sector’s most dynamic equities. Rocket Lab USA shares plummeted nearly 12% in a single trading session despite the company’s recent demonstration of strong operational performance. This dramatic movement raises questions about whether a previously published critical report could derail a compelling growth narrative.

Strong Fundamentals Contrast With Market Reaction

The company’s latest financial results present a markedly different picture from the market’s negative response. For the second quarter of 2025, Rocket Lab achieved a 36% revenue increase to $144.5 million, substantially exceeding analyst projections. Both the launch services division and space systems business contributed to this robust expansion.

However, the company reported earnings that fell short of expectations, posting a loss of $0.13 per share compared to the anticipated $0.07 per share loss. This mixed performance highlights the ongoing challenge of balancing growth investments with profitability.

Resurfaced Criticism Sparks Investor Concerns

The sharp decline appears directly linked to renewed attention on a short seller report originally circulated in February. This analysis casts doubt on development timelines for the Neutron rocket, which represents the cornerstone of Rocket Lab’s strategic vision. Although management maintains its commitment to achieving the inaugural Neutron launch before year-end 2025, the revived skepticism proved sufficient to trigger substantial selling pressure.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Neutron Program: Critical Path to Market Expansion

The successful and timely deployment of the Neutron rocket remains the pivotal factor in Rocket Lab’s competitive positioning. This medium-lift launch vehicle is designed to enable direct competition with established players in the medium-lift segment. Market researchers project that merely five to seven Neutron missions during 2026 could potentially drive annual revenue beyond $700 million.

The company appears well-positioned to execute this strategy, supported by a substantial $1.067 billion backlog and the recent operational launch of its Virginia-based launch facility.

Valuation Concerns Amid Substantial Expectations

Despite operational achievements, Rocket Lab’s elevated valuation continues to represent a risk consideration for investors. The company has not yet reached profitability and continues to allocate significant resources to Neutron development. With such high growth expectations already incorporated into the share price, even minor setbacks or delays can provoke outsized market reactions—explaining the pronounced sensitivity to the resurfaced critical analysis.